Avalo Therapeutics CEO and Key Executive Team

• Sol J. Barer

  Chairman of the Board
• Gilla Kaplan

  Director
• James A. Harrell

  Chief Commercial Officer
• Garry Neil

  Chief Scientific Officer
• Michael Cola

  Chief Executive Officer, Director
• Younok Dumortier Shin

  Chief Technology Officer
• Schond L. Greenway

  Chief Financial Officer
• H. Jeffrey Wilkins

  Chief Medical Officer
• Chris Sullivan

  Interim Chief Financial Officer
• Lisa Hegg

  Vice President Research and Development Programs and Project Management
• Colleen Matkowski

  Vice President Global Regulatory Affairs

Source: cerecor.com, cerecor.com, ir.avalotx.com, cerecor.com, ir.cerecor.com, cerecor.com, cerecor.com